Down -35.74% in 4 Weeks, Here's Why PDS Biotechnology (PDSB) Looks Ripe for a Turnaround [Yahoo! Finance]
PDS Biotechnology Co. (NASDAQ: PDSB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $21.00 price target on the stock.
PDS Biotechnology Corp (PDSB) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges ... [Yahoo! Finance]
PDS Biotech Provides Clinical Programs Update and Reports Third Quarter 2024 Financial Results [Yahoo! Finance]
PDS Biotech Provides Clinical Programs Update and Reports Third Quarter 2024 Financial Results